Selective induction of apoptosis of human oral cancer cell lines by avocado extracts via a ROS-mediated mechanism

Nutrition and Cancer

Volumn 61, Issue 3, 2009, Pages 348-356

  Ding, Haiming ^a   Han, Chunhua ^a   Guo, Dongmei ^a   Chin, Young Won ^b   Ding, Yi ^a   Kinghorn, A Douglas ^b   D'Ambrosio, Steven M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; AVOCADO EXTRACT; CHLOROFORM; D 003; FAS ASSOCIATED DEATH DOMAIN PROTEIN; HERBACEOUS AGENT; PLANT MEDICINAL PRODUCT; PROTEIN E6; PROTEIN E7; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG; BENZYLOXYCARBONYL ISOLEUCYL GLUTAMYL THREONYL ASPARTIC ACID FLUOROMETHYL KETONE; BENZYLOXYCARBONYL-ISOLEUCYL-GLUTAMYL-THREONYL-ASPARTIC ACID FLUOROMETHYL KETONE; FADD PROTEIN, HUMAN; OLIGOPEPTIDE; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AVOCADO; CANCER CELL CULTURE; CANCER PREVENTION; CANCER RESISTANCE; CONTROLLED STUDY; DRUG ISOLATION; DRUG TARGETING; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MOUTH CANCER; NONHUMAN; RESPIRATORY CHAIN; VIRUS CELL TRANSFORMATION; DRUG EFFECT; METABOLISM; MITOCHONDRION; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

PERSEA AMERICANA;

APOPTOSIS; CELL LINE, TUMOR; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; MITOCHONDRIA; MOUTH NEOPLASMS; OLIGOPEPTIDES; PERSEA; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 67649389995     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802567158     Document Type: Article

References (47)

1. Walker DM, Boey G, and McDonald LA: The pathology of oral cancer. Pathology 35, 376-383, 2003.
2. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52, 195-215, 2002.
3. La V, Altieri A, and Tavani A: Vegetables, fruit, antioxidants and cancer: A review of Italian studies. Eur J Nutr 40, 261-267, 2001.
4. Vainio H and Bianchini F: Evaluation of cancer-preventive agents and strategies: A new program at the International Agency for Research on Cancer. Ann NY Acad Sci 952, 177-180, 2001.
5. Byers TE: Nutrition and cancer: Ten lessons from the 20th century. Nutrition 16, 561-563, 2000.
6. Ding H, Chin YW, Kinghorn AD, and D'Ambrosio SM: Chemopreventive characteristics of avocado fruit. Semin Cancer Biol 17, 386-394, 2007.
7. Lu QY, Arteaga JR, Zhang Q, Huerta S, Go VL, et al.: Inhibition of prostate cancer cell growth by an avocado extract: Role of lipid-soluble bioactive substances. J Nutr Biochem 16, 23-30, 2005.
8. Oberlies NH, Rogers LL, Martin JM, and McLaughlin JL: Cytotoxic and insecticidal constituents of the unripe fruit of Persea americana. J Nat Prod 61, 781-785, 1998.
9. Nichenametla SN, Taruscio TG, Barney DL, and Exon JH: A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 46, 161-183, 2006.
10. Lee H, Li D, Prior T, Casto BC,Weghorst CM, et al.: Ineffectiveness of the presence of h-ras/p53 combination mutations in squamous cell carcinoma cells to induce the conversion of a nontumorigenic to a tumorigenic tumor type. Cell Biol Toxicol 13, 419-434, 1997.
11. Milo GE, Shuler C, Kurian P, French BT, Mannix DG, et al.: Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS orMYC. Proc Natl Acad Sci USA 87, 1268-1272, 1990.
12. D'Ambrosio SM, D'Ambrosio REG, Milo GE, Casto BC, Kelloff GJ, et al.: Differential growth responses of normal, premalignant, and malignant human oral epithelial cells by chemopreventive agents. Anticancer Res 20, 2273-2280, 2000.
13. Gibson-D'Ambrosio RE, Samuel M, and D'Ambrosio SM: A method for isolating large numbers of viable disaggregated cells from various human tissues for cell culture establishment. In Vitro Cell Dev Biol 22, 529-534, 1986.
14. Morgan MJ, Thorburn J, Thomas L, Maxwell T, Brothman AR, et al.: An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells. Cell Death Differ 8, 696-705, 2001.
15. Ding H, Han C, Guo D,Wang D, DuanW, et al.: Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21WAF1/CIP1 dependent. Int J Cancer, 2008. Forthcoming.
16. Wall ME, Wani MC, Brown DM, Fullas F, Oswald JB, et al.: Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine 3, 281-285, 1996.
17. Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, et al.: Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol 41, 53-67, 2003.
18. Ding H, Han C, Gibson-D'Ambrosio R, Steele VE, and D'Ambrosio SM: Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1. Int J Cancer 107, 830-836, 2003.
19. Ding H, Han C, Zhu J, Chen CS, and D'Ambrosio SM: Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Int J Cancer 113, 803-810, 2005.
20. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 326(Pt 1), 1-16, 1997.
21. Slee EA, Harte MT, Kluck RM,Wolf BB, Casiano CA, et al.: Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases- 2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144, 281-292, 1999.
22. Turrens JF,AlexandreA, and LehningerAL: Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237, 408-414, 1985.
23. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, et al.: Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 272, 21388-21395, 1997.
24. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, et al.: Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95, 1772-1783, 2003.
25. Kim HW, Murakami A, Nakamura Y, and Ohigashi H: Screening of edible Japanese plants for suppressive effects on phorbol ester-induced superoxide generation in differentiated HL-60 cells and AS52 cells. Cancer Lett 176, 7-16, 2002.
26. Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51, 794-798, 1991.
27. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, et al.: Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 10, 241-252, 2006.
28. Schumacker PT: Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 10, 175-176, 2006.
29. Lee KWand Lee HJ: The roles of polyphenols in cancer chemoprevention. Biofactors 26, 105-121, 2006.
30. Fang J, Lu J, and Holmgren A: Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J Biol Chem 280, 25284-25290, 2005.
31. Johnson MK and Loo G: Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat Res 459, 211-218, 2000.
32. Martin KR: Targeting apoptosis with dietary bioactive agents. Exp BiolMed 231, 117-129, 2006.
33. Sheu SS, Nauduri D, and AndersMW: Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim Biophys Acta 1762, 256-265, 2006.
34. Fruehauf JP and Meyskens FL Jr: Reactive oxygen species: A breath of life or death? Clin Cancer Res 13, 789-794, 2007.
35. Lopez-Lazaro M: Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy. Cancer Lett 252, 1-8, 2007.
36. Xia S, Rosen EM, and Laterra J: Sensitization of glioma cells to Fasdependent apoptosis by chemotherapy-induced oxidative stress. Cancer Res 65, 5248-5255, 2005.
37. Simizu S, Takada M, Umezawa K, and Imoto M: Requirement of caspase- 3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 273, 26900-26907, 1998.
38. Alexandre J,Batteux F,Nicco C, Chereau C, LaurentA, et al.:Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119, 41-48, 2006.
39. Mizutani H, Tada-Oikawa S, Hiraku Y, KojimaM, and Kawanishi S:Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci 76, 1439-1453, 2005.
40. Jing Y, Dai J, Chalmers-Redman RM, TattonWG, andWaxman S: Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94, 2102-2111, 1999.
41. Jin Z and El-DeiryWS: Overview of cell death signaling pathways. Cancer Biol Ther 4, 139-163, 2005.
42. Bayir H, Fadeel B, Palladino MJ, Witasp E, Kurnikov IV, et al.: Apoptotic interactions of cytochrome c: Redox flirting with anionic phospholipids within and outside of mitochondria. Biochim Biophys Acta 1757, 648-659, 2006.
43. Brenner C and Grimm S: The permeability transition pore complex in cancer cell death. Oncogene 25, 4744-4756, 2006.
44. Karunagaran D, Rashmi R, and Kumar TR: Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 5, 117-129, 2005.
45. Kwon KB, Park BH, and Ryu DG: Chemotherapy through mitochondrial apoptosis using nutritional supplements and herbs: A brief overview. J Bioenerg Biomembr 39, 31-34, 2007.
46. Huang HL, Fang LW, Lu SP, Chou CK, Luh TY, et al.: DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation. Oncogene 22, 8168-8177, 2003.
47. Cagnol S, Van Obberghen-Schilling E, and Chambard JC: Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death. Apoptosis 11, 337-346, 2006.